Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy

The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy

(2009) Xia Wu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Review role of topotecan in gynaecological cancers: Current indications and perspectives

(2009) Domenica Lorusso et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The emergence of immunomodulation: Combinatorial immunochemotherapy opportunities for the next decade

(2009) Lana E. Kandalaft et al.   GYNECOLOGIC ONCOLOGY

A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer

(2008) M. J. Robertson et al.   CLINICAL CANCER RESEARCH

The Immune Adjuvant Properties of Front-line Carboplatin-Paclitaxel: A Randomized Phase 2 Study of Alternative Schedules of Intravenous Oregovomab Chemoimmunotherapy in Advanced Ovarian Cancer

(2008) Patricia Braly et al.   JOURNAL OF IMMUNOTHERAPY

Whole tumor antigen vaccination using dendritic cells: Comparison of RNA electroporation and pulsing with UV-irradiated tumor cells

(2008) Fabian Benencia et al.   Journal of Translational Medicine